Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.54 |
| ▸ | GSR | P00390 | 1/20 | 0.50 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.48 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.46 |
| ▸ | GGT1 | P19440 | 1/20 | 0.44 |
| ▸ | MMP2 | P08253 | 1/20 | 0.44 |
| ▸ | MMP9 | P14780 | 1/20 | 0.44 |
| ▸ | CPB2 | Q96IY4 | 10/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | TLR2 | O60603 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7225798 | 1.00 | FOLH1 (0.54) | FOLH1GSRRNPEPSLC6A5GGT1 | |
| SCHEMBL7198357 | 0.94 | FOLH1 (0.47) | FOLH1GSRRNPEPSLC6A5GGT1 | |
| SCHEMBL8768872 | 0.94 | FOLH1 (0.47) | FOLH1GSRRNPEPSLC6A5GGT1 | |
| Hydrochloric Acid SCHEMBL10780765 | 0.92 | FOLH1 (0.46) | FOLH1GSRRNPEPSLC6A5GGT1 | |
| SCHEMBL50111 | 0.86 | FOLH1 (0.57) | FOLH1GSRRNPEPSLC6A5GGT1 | |
| SCHEMBL43620 | 0.86 | FOLH1 (0.57) | FOLH1GSRRNPEPSLC6A5GGT1 | |
| SCHEMBL28526909 | 0.85 | FOLH1 (0.51) | FOLH1GSRRNPEPSLC6A5GGT1 | |
| SCHEMBL5419509 | 0.85 | FOLH1 (0.51) | FOLH1GSRRNPEPSLC6A5GGT1 | |
| SCHEMBL25396641 | 0.85 | FOLH1 (0.51) | FOLH1GSRRNPEPSLC6A5GGT1 | |
| Water SCHEMBL380638 | 0.85 | FOLH1 (0.56) | FOLH1GSRRNPEPSLC6A5GGT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108866103-B | Soybean fermentation metabolite and application thereof | 仙婷(广州)贸易有限公司 | 2021-05-18 | — | — | CN | claimed |
| CN-108866103-A | A kind of fermented soybean metabolin and its application | 广州市仙婷贸易有限公司 | 2018-11-23 | — | — | CN | claimed |
| EP-0792146-A1 | INACTIVATION OF PATHOGENS USING HYDROXYMETHYLAMINES | HEMASURE, INC. (US) | 1997-09-03 | — | — | EP | claimed |
| WO-1997002028-A1 | INACTIVATION OF PATHOGENS USING HYDROXYMETHYLAMINES | HEMASURE, INC. (US) | 1997-01-23 | — | — | WO | claimed |
| CN-118666993-B | Ningxia beef cattle hemoglobin source antioxidant peptide, preparation method and identification method | 合肥工业大学 | 2024-11-29 | — | — | CN | disclosed |
| CN-118666993-A | Ningxia beef cattle hemoglobin source antioxidant peptide, preparation method and identification method | 合肥工业大学 | 2024-09-20 | — | — | CN | disclosed |
| CN-117925503-A | Application of PSGAs autoantibodies in serum/plasma in early diagnosis of diabetic nephropathy | 连步生物科技(南京)有限公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-114652648-A | Novel freeze-dried mask and preparation method thereof | 深圳津梁生活科技有限公司 | 2022-06-24 | — | — | CN | disclosed |
| CN-108866103-B | Soybean fermentation metabolite and application thereof | 仙婷(广州)贸易有限公司 | 2021-05-18 | — | — | CN | disclosed |
| CN-109239350-A | Body fluid AGEs autoantibody is preparing the application in diabetogenous nephrosis disease early diagnosis reagent | 连步生物科技(南京)有限公司 | 2019-01-18 | — | — | CN | disclosed |
| CN-108866103-A | A kind of fermented soybean metabolin and its application | 广州市仙婷贸易有限公司 | 2018-11-23 | — | — | CN | disclosed |
| WO-2017181255-A1 | FOOD SUPPLEMENT FOR RUMINANTS BASED ON IGY ANTIBODIES AGAINST STREPTOCOCCUS EQUINUS AND ARCHAEA METHANOGENS ASSOCIATED WITH L-LYSIN HCL AND ALPHA-AMYLASE, METHOD FOR PRODUCING SAME AND USES THEREOF | AGÊNCIA PAULISTA DE TECNOLOGIA DOS AGRONEGÓCIOS - APTA (BR) | 2017-10-26 | — | — | WO | disclosed |
| CN-102883733-B | AGE production inhibitor | ORYZA OIL & FAT CHEM | 2014-08-13 | — | — | CN | disclosed |
| CN-102883733-A | AGE production inhibitor | ORYZA OIL & FAT CHEM | 2013-01-16 | — | — | CN | disclosed |
| US-6602910-B2 | Treating cancer in a patient comprising administering an effective amount of substantially purified D enantiomer of difluoromethylornithine | ILEX ONCOLOGY, INC. | 2003-08-05 | — | — | US | disclosed |
| US-20020045663-A1 | D-enantiomer of DFMO and methods of use therefor | ILEX ONCOLOGY, INC. (US) | 2002-04-18 | — | — | US | disclosed |
| EP-0792146-A1 | INACTIVATION OF PATHOGENS USING HYDROXYMETHYLAMINES | HEMASURE, INC. (US) | 1997-09-03 | — | — | EP | disclosed |
| WO-1997002028-A1 | INACTIVATION OF PATHOGENS USING HYDROXYMETHYLAMINES | HEMASURE, INC. (US) | 1997-01-23 | — | — | WO | disclosed |
| US-4085229-A | TO OBTAIN PROTEINS FOR ANIMAL AND HUMAN FEEDING, HYDROLYSIS WITH YEASTS OR FUNGI, SOLUBILIZING, ACIDIFYING | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) | 1978-04-18 | — | — | US | disclosed |
| US-4073945-A | CALCIUM SALT OF MONO- OR BIS-HYDROXYMETHYL-LYSINE | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) | 1978-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020045663-A1 | D-enantiomer of DFMO and methods of use therefor | DHODH, DDT, HADHB | FOLH1 39/4885GSR 1038/4885RNPEP 1764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.